Skip to main content
. 2022 Nov 9;23:69–79. doi: 10.1016/j.bioactmat.2022.09.027

Fig. 7.

Fig. 7

Overview of (pMETTL14+RS09)@cRGD-M in dual-targeted tumor therapy. (A) (pMETTL14+RS09)@cRGD-M nanovesicles had the ability of dual-targeting tumor and macrophages. (B) (pMETTL14+RS09)@cRGD-M nanovesicles could target to inhibit tumor and induce M1 polarization of macrophages, thereby achieving the dual purposes of tumor inhibition and macrophage polarization.